EU Import Testing Requirements
Under EU Directive 2001/83/EC, pharmaceutical imports require GMP testing in an EU laboratory before market release.
Legal Requirement
EU Directive 2001/83/EC, Article 51(1)(b) requires that imported pharmaceutical products undergo quality control testing in a Member State at an EU GMP-certified laboratory before Qualified Person (QP) certification and market authorization.
References: Directive 2001/83/EC (Article 51), EudraLex Volume 4 (Annex 16, Annex 21)
What Requires EU GMP Testing
1. Finished Medicinal Products
Article 51(1)(b): Each imported batch must undergo in a Member State:
- Full qualitative analysis
- Quantitative analysis of all active substances
- Additional quality tests per marketing authorization
Exception: MRA countries (Switzerland, USA, Canada, Japan, Australia) — QP may rely on exporting country testing
Mandatory for: Imports from China, India, most of Asia, South America, non-MRA territories
2. Raw Materials (APIs & Excipients)
EudraLex Volume 4, Part II: Imported active pharmaceutical ingredients and excipients must meet EU GMP standards.
- Identity verification (XRPD per USP<941>, Ph.Eur<2.9.33>)
- Purity and impurity assessment
- Polymorphic form characterization
- Specification compliance testing
3. Intermediates & Bulk Products
Annex 21: Importers must hold Manufacturing and Import Authorization (MIA). Quality control testing under EU GMP required before QP certification.
- Identity and purity verification
- Compliance with specifications
- Testing in EU GMP laboratory
DANNALAB EU GMP Compliance
EU GMP Certified
Confirmed by Dutch Health Care Inspectorate (2024)
Netherlands Location
EU Member State — fulfills "in a Member State" requirement
QP-Ready Reports
Documentation suitable for QP certification
XRPD Testing
Pharmacopoeia-compliant (USP<941>, Ph.Eur<2.9.33>)
Regulatory References
- Directive 2001/83/EC — Article 51(1)(b): Import testing requirements
- Regulation (EU) 2019/6 — Veterinary medicinal products
- EudraLex Volume 4 — Annex 16 (QP Certification), Annex 21 (Importation), Part II (Active Substances)
Consult current legislation and regulatory advisors for specific scenarios. DANNALAB provides analytical testing; regulatory strategy remains client responsibility.
Contact for EU Import Testing
DANNALAB provides EU GMP-compliant analytical testing for pharmaceutical imports, supporting your import authorization and QP certification requirements.